Oncology

PDS Biotech's PDS01ADC Shows 78% Response Rate in Metastatic Colorectal Cancer Phase 2 Trial

Oncology - Metastatic Colorectal Cancer · 3 min

ASCO 2026: GI Innovation's GI-101A Phase 1 Data Preview

oncology · 2 min

FDA Approval NanoPharm Therapy: Accelerated OK for Metastatic Breast Cancer

FDA · Metastatic breast cancer · 8 min

Actuate Therapeutics' Elraglusib Doubles Pancreatic Cancer Survival Rates in Nature Medicine Study

Metastatic Pancreatic Cancer · 3 min

FDA Approves Elahere: Expanded Use for Platinum-Resistant Ovarian Cancer

FDA · Ovarian Cancer · 4 min

FDA Approval TRK Inhibitor: OncoCure's Breakthrough for NTRK Tumors

FDA · Oncology · 4 min

FDA Approves CART-T20: Novel CAR-T Therapy for Mantle Cell Lymphoma

FDA · Mantle Cell Lymphoma · 8 min

FDA Breakthrough Therapy TargTex TX202: What You Need to Know

FDA · Glioblastoma · 6 min

FDA Approves BriaCell's Bria-IMT: Novel CAR-T Therapy for Advanced Breast Cancer

FDA · Breast Cancer · 4 min

FDA Approval OncoBlock: Accelerated Approval for Refractory AML

FDA · Acute Myeloid Leukemia · 6 min

FDA Approves Xylocor: Novel Advanced Melanoma Treatment by Xylos Bio

FDA · Advanced Melanoma · 6 min

FDA Approves Tecentriq for Extensive-Stage Small Cell Lung Cancer

FDA · oncology · 4 min